课题基金 / 基金详情

Enrichment Program

Enrichment Program
强化计划
批准号:
10197909
负责人:
Justin Pierce Annes
金额:
$9.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2022-06-30

项目摘要

项目成果

Justin Pierce Annes的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary: Enrichment, Training, and Outreach in the Stanford DRC Stanford University and School of Medicine are renowned leaders in education, scientific innovation, patient care and entrepreneurship. A central aspect of the Stanford Diabetes Research Center (SDRC) Enrichment, Training, and Outreach Program is to leverage these strengths to enhance diabetes research and training. The goals of the SDRC Enrichment, Training and Outreach Program (ETOP) are: 1) To advance diabetes research by serving as the organizing nexus of enrichment activities to foster interdisciplinary education, idea sharing and collaboration; 2) To attract, support and train future diabetes research leaders who will advance diabetes-related knowledge and improve patient care; 3) To facilitate and support the numerous local and national community outreach programs that Stanford has established to improve patient awareness, empowerment and advocacy. The SDRC enhances the environment for diabetes research and training at Stanford through multiple efforts including the establishment of diabetes-research affinity groups to facilitate knowledge-sharing and collaboration, a monthly diabetes research-in-progress seminar series, multiple lecture series for invited speakers, an annual Diabetes Research Day Symposium that showcases new and evolving ideas in the field, a spectrum of training grant opportunities including NIH T32 training programs and numerous patient-oriented events that occur on campus as well as within the community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing A Platform Technology For β-Cell-Targeted Drug Delivery
  • 批准号:
    10729390
  • 项目类别:
  • 资助金额:
    $55.62万
  • 财政年份:
    2023
  • 负责人:
    Justin Pierce Annes
  • 依托单位:
Development of Beta-Cell-Targeted Regenerative Therapeutics Using A Novel Prodrug Strategy
  • 批准号:
    10215497
  • 项目类别:
  • 资助金额:
    $42.68万
  • 财政年份:
    2019
  • 负责人:
    Justin Pierce Annes
  • 依托单位:
Development of Beta-Cell-Targeted Regenerative Therapeutics Using A Novel Prodrug Strategy
  • 批准号:
    10661006
  • 项目类别:
  • 资助金额:
    $42.68万
  • 财政年份:
    2019
  • 负责人:
    Justin Pierce Annes
  • 依托单位:
Development of Beta-Cell-Targeted Regenerative Therapeutics Using A Novel Prodrug Strategy
  • 批准号:
    10453575
  • 项目类别:
  • 资助金额:
    $42.68万
  • 财政年份:
    2019
  • 负责人:
    Justin Pierce Annes
  • 依托单位:
海外基金